Peer-influenced content. Sources you trust. No registration required. This is HCN.

MedPage TodayQuestioning Aspirin’s Role After Percutaneous Coronary Intervention and Acute Coronary Syndrome

Most current guidelines recommend at least 12 months of dual anti-platelet therapy for ACS and post PCI. But is that the best approach in an aging population with inherent higher bleeding risk? Some are advocating very early cessation of aspirin as well as scaling down the P2Y12 inhibitor in the first few months post event.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form